Advances of CD19-directed chimeric antigen receptor-modified T cells in refractory/relapsed acute lymphoblastic leukemia
Crossref DOI link: https://doi.org/10.1186/s40164-017-0070-9
Published Online: 2017-04-14
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Wei, Guoqing
Ding, Lijuan
Wang, Jiasheng
Hu, Yongxian
Huang, He
Funding for this research was provided by:
the 973 Program (2015CB964900)